|

SHR-A1904; Adebrelimab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Shanghai Hengrui Pharmaceutical Co., Ltd.1

Indications

  • CLDN18.2-positive Advanced Solid Tumor1
  • Cancer1

Other1 trial

SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.